Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
11/2008
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008CN101311181A Aminomethyl-substituted thiazolobenzimidazole derivative
11/26/2008CN101311176A Isoquinoline compounds, preparation method and use thereof
11/26/2008CN100436455C Substitute 2,3-dihydrogen thiazole [4,5-d] pyrimidine-7(6H)- ketone (imines) having weed removal active and preparation thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/20/2008WO2008138753A1 Hetarylanilines as modulators for amyloid beta
11/20/2008US20080287511 Anthelmintic Imidazol-Thiazole Derivates
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287473 Novel molecules for regulating cell death
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287434 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/20/2008CA2686754A1 Hetarylanilines as modulators for amyloid beta
11/19/2008EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
11/19/2008EP1991549A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
11/19/2008EP1745054B1 Dealkylated derivatives of pyrrolo(2,1-b)benzothiazepines with atypical antipsychotic activity
11/19/2008CN101309925A Fused tetracyclic mglur1 antagonists as therapeutic agents
11/18/2008US7452993 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
11/18/2008US7452903 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2305802C Amide derivatives or salts thereof
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136444A1 Fused heterocyclic derivative
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008135524A2 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
11/13/2008WO2008135291A1 New progesterone receptor modulators
11/13/2008WO2008082562A3 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
11/13/2008WO2008039520A3 Fused ring compounds for inflammation and immune-related uses
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008WO2008005908A3 Pyridoimidazole derivatives
11/13/2008US20080280948 Modulators of amyloid beta
11/13/2008US20080280892 Tricyclic nitrogen antibacterial; 1-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one; may be used with other active ingredients, diluents
11/13/2008US20080280888 Antibiotics Derivatives
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684088A1 New progesterone receptor modulators
11/13/2008CA2674831A1 5,6-ring annulated indole derivatives and methods of use thereof
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1692143B1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008CN101305011A Pyridine derivatives and their use in the treatment of psychotic disorders
11/12/2008CN101304997A Bridged N-bicyclic sulfonamido inhibitors of gamma secretase
11/12/2008CN100432077C N-sulfonylaminothiazole
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/06/2008WO2008134679A1 Inhibitors of iap
11/06/2008WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups
11/06/2008WO2008132114A1 Process for the preparation of brinzolamide and intermediates thereof
11/06/2008WO2008075155A3 Carbonic anhydrase inhibitors derivatives
11/06/2008US20080275235 Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group
11/06/2008CA2683392A1 Inhibitors of iap
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
10/2008
10/30/2008WO2008131415A1 4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,9h)-diones and related compounds as anti-infective agents
10/30/2008WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
10/30/2008WO2008059368A3 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
10/30/2008WO2008016648A3 Certain chemical entities, compositions and methods
10/30/2008US20080269238 Thiazolopyrimidine Derivative
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269195 Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine
10/30/2008US20080269061 Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones
10/30/2008CA2684003A1 Novel compounds as cannabinoid receptor ligands
10/29/2008EP1985618A1 Process for the preparation of brinzolamide and intermediates thereof
10/29/2008EP1983993A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/28/2008US7442795 Triazole compounds useful in therapy
10/28/2008CA2355857C 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/22/2008EP1981883A1 Novel heteroaryl substituted benzothiazoles
10/22/2008EP1981881A1 Tetrahydropyrane antibiotics
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008CN101291939A Thiazolo[4,5-C]pyridine derivatives as mGluR5 receptor antagonists
10/22/2008CN101289455A Anti-influenza virus precursor drug and uses thereof
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
10/21/2008CA2171334C Substituted thiazolo[3,2-a]azepine derivatives
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008076883A3 Triazine derivatives and their therapeutical applications
10/16/2008US20080255176 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008US20080255101 spiro[2H-1,2,4-benzothiadiazine-3,4'-piperidin]-1'-yloxy,7-(aminosulfonyl)-6-chloro-2',2',6',6'-tetramethyl-1,1-dioxide; antidiabetic agent; electrolyte retention; cardiovascular diseases; renovascular diseases; oxidative stress; endothelial dysfunctions; endothelial dysfunctions; cirrhosis; osteoporosis
10/15/2008EP1979360A1 Compounds and compositions as ppar modulators
10/15/2008EP1979343A2 Bicyclic heteroaryl compounds as pde10 inhibitors
10/15/2008EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 152